Origen de la red de primer grado Paul Francis Hope.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Snoody Ltd.
Snoody Ltd. Medical SpecialtiesHealth Technology Snoody Ltd. develops and supplies antiviral and healing technology for various product applications. It provides wound dressings, mastitis prevention products, ulcer preventing socks, face masks, and integrated pathogen defense products. The company was founded in 2009 by Paul Francis Hope and is headquartered in Manchester, the United Kingdom.
5
| Private Company | Medical Specialties | 5 |
Virustatic Shield Ltd.
Virustatic Shield Ltd. Internet RetailRetail Trade Part of Snoody Ltd., Virustatic Shield Ltd. sells face coverings through online. The company is based in Gaerwen, UK.
3
| Subsidiary | Internet Retail | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Paul Francis Hope a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA. | Pharmaceuticals: Major | Director/Board Member | |
Attralus, Inc.
Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
ELEVATION ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
venBio Partners LLC
venBio Partners LLC Investment ManagersFinance venBio Partners LLC (venBio) is a venture capital subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
PHARVARIS N.V. | Pharmaceuticals: Major | Director/Board Member | |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Biotechnology | Director/Board Member | |
Stargazer Pharmaceuticals, Inc.
Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
PLIANT THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
University of Pennsylvania | College/University | Undergraduate Degree | |
Stanford University | College/University | Doctorate Degree | |
VENTYX BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Locki Therapeutics Ltd.
Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Biotechnology | Director/Board Member | |
35Pharma, Inc.
35Pharma, Inc. Pharmaceuticals: MajorHealth Technology 35Pharma, Inc. designs and develops biologics for diseases of high unmet medical need. The CEO of the Canadian company is Ilia A. Tikhomirov. | Pharmaceuticals: Major | Director/Board Member | |
Entact Bio, Inc.
Entact Bio, Inc. BiotechnologyHealth Technology Entact Bio, Inc. is a company that focuses on creating new medicines by enhancing protein function. The company is based in Watertown, MA. The company is a team of scientists, entrepreneurs, drug creators, and problem solvers who work together to bring new medicines to patients who currently have few options. The CEO of the company is Victoria M. Richon. The founder of the company grew up in chaos and instability in an undisclosed capital city and has always been passionate and motivated to help enhance and provide medical solutions. | Biotechnology | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 12 |
Países Bajos | 3 |
Suiza | 2 |
Reino Unido | 2 |
Canadá | 2 |
Sectorial
Health Technology | 14 |
Consumer Services | 3 |
Finance | 2 |
Operativa
Director/Board Member | 17 |
Founder | 2 |
Chief Executive Officer | 1 |
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Paul Francis Hope
- Conexiones Empresas